FindTrial
Sign In

PROTOXIN

BIOLOGICAL3 trials

Sponsors

Protox Inc.

Conditions

Glabellar Frown Lines

Phase 1

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines
CompletedNCT04996810
Protox Inc.Glabellar Frown Lines
Start: 2020-12-10End: 2021-05-26Updated: 2021-08-10

Phase 3

The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines
CompletedNCT05364580
Protox Inc.Glabellar Frown Lines
Start: 2023-03-06End: 2023-10-06Updated: 2023-11-18
The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines
CompletedNCT06124794
Protox Inc.Glabellar Frown Lines
Start: 2023-12-18End: 2024-06-14Updated: 2024-06-21

Related Papers

Efficacy and Safety of Novel Botulinum Toxin Type A (Protoxin) in the Treatment of Moderate to Severe Glabellar Lines: A Multicenter, Randomized, Double-Blind, Active-Controlled Phase III Study
Annals of Dermatology2025-11-20